Search results for " BLADDER"

showing 10 items of 396 documents

The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among Clinicians.

2017

Abstract Introduction Guidelines recommend neoadjuvant chemotherapy (NAC) before radical cystectomy (RC) in patients with urothelial carcinoma of the bladder in clinical stages T2-T4a, cN0M0. We examined the frequency and current practice of NAC and sought to identify predictors for the use of NAC in a prospective contemporary cohort. Materials and Methods We analyzed prospective data from 679 patients in the PROMETRICS (PROspective MulticEnTer RadIcal Cystectomy Series 2011) database. All patients underwent RC in 2011. Uni- and multivariable regression analyses identified predictors of NAC application. Furthermore, a questionnaire was used to evaluate the practice patterns of NAC at the PR…

Malemedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyCystectomyCystectomy03 medical and health sciences0302 clinical medicineSex FactorsInternal medicineSurveys and QuestionnairesmedicineHumansIn patientProspective StudiesPractice Patterns Physicians'AgedNeoplasm StagingChemotherapyCarcinoma Transitional Cellbusiness.industryAge FactorsCancerMultimodal therapyGuidelineMiddle Agedmedicine.diseaseSurgeryOncologyUrinary Bladder NeoplasmsCurrent practiceChemotherapy Adjuvant030220 oncology & carcinogenesisCohortFemalebusinessClinical genitourinary cancer
researchProduct

Treatment of Iatrogenic Functional or Morphologic Bladder Loss

1988

From 1984 to 1986, six children from 4 to 13 years of age, received a bladder augmentation by ileocecal cystoplasty (Mainz-pouch technique) because of an iatrogenic functional or morphologic bladder loss. Indications for operation were incontinence due to the low bladder capacity or threat to the upper urinary tract due to ureteral obstruction or vesicorenal reflux. Two of the children had already undergone supravesical urinary diversion by sigmoid conduit. After a follow-up period of 2 to 19 months, (mean 11 months), five of the six children are completely continent. One boy with a known weak sphincter still has slight, but decreasing, enuresis nocturna in periods of complete filling of th…

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentIatrogenic DiseaseUrinary BladderBladder capacityUrinary Diversionurologic and male genital diseasesEnuresis nocturnaPostoperative ComplicationsIleummedicineHumansChildCecumUpper urinary tractbusiness.industryUrinary diversionUrinary Bladder DiseasesRefluxGeneral MedicineUrination Disordersfemale genital diseases and pregnancy complicationsSurgerymedicine.anatomical_structureBladder augmentationChild PreschoolPediatrics Perinatology and Child HealthSphincterSurgeryFemalePouchbusinessJournal of Urology
researchProduct

Persistent storage symptoms after TURP can be predicted with a nomogram derived from the ice water test

2019

PURPOSE To predict the persistence of storage symptoms after transurethral resection of the prostate (TURP) using a nomogram derived from the ice water test (IWT). METHODS The IWTs of 73 men with lower urinary tract symptoms and prostatic bladder outlet obstruction were retrospectively analyzed. The strength of the detrusor contraction was approximated by using the detrusor gradient of Δpdet /Δt at maximum detrusor pressure and the area under the curve. The parameters were utilized in a nomogram, which facilitated a severity categorization from 1 to 10. Patients with a positive IWT in the categories 1 to 2 were assigned to group A, categories 3 to 4 to group B and categories 5 and higher to…

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentProstatic Hyperplasia030232 urology & nephrologyUrologyurologic and male genital diseasesGroup BPersistence (computer science)03 medical and health sciencesBladder outlet obstruction0302 clinical medicineLower Urinary Tract SymptomsLower urinary tract symptomsmedicineHumansAgedRetrospective StudiesTransurethral resection of the prostateAged 80 and over030219 obstetrics & reproductive medicineUrinary Bladder Overactivebusiness.industryTransurethral Resection of ProstateArea under the curveDiagnostic Techniques UrologicalMiddle AgedNomogrammedicine.diseaseBotulinum toxinUrinary Bladder Neck ObstructionNomogramsUrodynamicsNeurology (clinical)businessmedicine.drugNeurourology and Urodynamics
researchProduct

Extent of Surgery in Rhabdomyosarcoma of Urogenital Structures

1989

After high inguinal semicastration in group-1 paratesticular rhabdomyosarcoma (RMS), the patient having undergone chemotherapy can be followed closely by CT scanning without retroperitoneal lymphadenectomy. In contrast, retroperitoneal RMS should be operated on as radically as possible after downstaging the tumor mass. In RMS of the female genitalia locally limited organ-preserving surgery is the method of choice. The prognosis is excellent with adjuvant chemotherapy. Only 20% of all bladder RMS arise from the bladder dome or the movable part of the bladder, where primary partial resection including a safety margin of 3 cm of healthy tissue is possible. The majority, however, arising from t…

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentProstatic urethraAntineoplastic Combined Chemotherapy ProtocolsRhabdomyosarcomamedicineHumansChildRhabdomyosarcomaUpper urinary tractGenitourinary systembusiness.industryUrinary diversionRadiotherapy DosagePrognosismedicine.diseaseCombined Modality TherapySurgeryNeck of urinary bladdermedicine.anatomical_structureFemalebusinessContinent Urinary DiversionUrogenital NeoplasmsChemoradiotherapyFollow-Up StudiesEuropean Urology
researchProduct

Coincident vesical transitional cell carcinoma and prostatic carcinoma. Clinical features and treatment.

1986

Summary— Twenty-two patients with vesical urothelial carcinoma associated with prostatic carcinoma were reviewed. They represented 1.5% of the bladder and prostatic tumours treated in our department within a 12-year period from 1968 to 1979. Their management included several treatment policies, based on the separate assessment of each tumour variant. For non-infiltrating bladder tumours, transurethral tumour resection was combined with hormonal treatment, external radiotherapy or resection of the prostate depending on the stage of the prostatic tumour. Radical cystoprostatectomy was performed for two cases of infiltrating bladder tumour with well localised prostatic tumours. A conservative …

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentTumor resectionUrologyCystoprostatectomyNeoplasms Multiple PrimaryProstatemedicineCarcinomaHumansNeoplasm InvasivenessStage (cooking)PathologicalAgedCarcinoma Transitional Cellbusiness.industryCancerProstatic NeoplasmsMiddle Agedmedicine.diseasePrognosismedicine.anatomical_structureTransitional cell carcinomaUrinary Bladder NeoplasmsbusinessBritish journal of urology
researchProduct

Colon pouch (Mainz III) for continent urinary diversion

2007

OBJECTIVE To evaluate the use of a continent cutaneous pouch made exclusively of colon (Mainz pouch III), as excellent results with the Mainz pouch III in irradiated patients suggested that the indication for this type of urinary diversion could be extended. PATIENTS AND METHODS The outcome of 24 patients with continent cutaneous urinary diversions using colon segments (Mainz pouch III) was investigated retrospectively. Overall, 22 of the patients had a malignant disease and two a benign disease; 16 had a hysterectomy and pelvic exenteration for gynaecological tumours; two men with a rhabdomyosarcoma of the prostate had a radical cystoprostatectomy; one woman had pelvic exenteration for bla…

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentUrinary systemUrologyColonic PouchesUrinary DiversionCystectomyPostoperative ComplicationsColon SigmoidHumansMedicineNeurogenic bladder dysfunctionRetrospective StudiesBladder cancerPelvic exenterationbusiness.industryAnastomosis SurgicalUrinary Reservoirs ContinentUrinary diversionmedicine.diseaseSurgeryTreatment OutcomeFemalePouchbusinessContinent Urinary DiversionUrogenital NeoplasmsFollow-Up StudiesBJU International
researchProduct

Urethral Tumor Recurrences after Radical Cystoprostatectomy: The Case for Primary Cystoprostatourethrectomy?

1990

Of 273 male patients who underwent radical cystoprostatectomy between 1967 and 1987, 22 were regarded as at risk for urethral recurrence. These patients underwent simultaneous primary urethrectomy or urethrectomy shortly after cystectomy because of the histology of the cystectomy specimen. Of the remaining 251 patients a urethral recurrence was observed in 23 (9.2%). A patient with a urethral recurrence originally had undergone an operation at another hospital. The first urethral tumor recurrence was observed in 1977 but between October 1987 and May 1988, 7 patients were treated for an initial or secondary urethral recurrence. This finding suggests that the rate of urethral recurrence incre…

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyCystectomyCystoprostatectomyCystectomyUrethraUrethrectomymedicineCarcinomaHumansProstatectomyUrethral NeoplasmsEpitheliomaRadical cystoprostatectomybusiness.industryProstatectomymedicine.diseaseSurgeryUrethramedicine.anatomical_structureUrinary Bladder NeoplasmsNeoplasm Recurrence LocalbusinessJournal of Urology
researchProduct

Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.

2005

OBJECTIVES To report the long-term follow-up of patients with locally advanced bladder cancer treated with either adjuvant combined chemotherapy with methotrexate, vinblastine, doxorubicin/epirubicin, and cisplatin (MVAC/MVEC) or no additional treatment after radical cystectomy, to examine various survival endpoints and factors associated with long-term survival. PATIENTS AND METHODS Between May 1987 and December 1990, 49 patients undergoing radical cystectomy for locally advanced bladder cancer were randomized to observation only or adjuvant systemic chemotherapy with three cycles of MVAC/MVEC (methotrexate 30 mg/m2 on day 1, 15 and 22; vinblastine 3 mg/m2 on day 2, 15 and 22; doxorubicin …

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyCystectomyVinblastineDisease-Free SurvivalCystectomyAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansAgedEpirubicinChemotherapyBladder cancerbusiness.industryHazard ratioCombination chemotherapyMiddle Agedmedicine.diseaseInterim analysisCombined Modality TherapyVinblastineSurgeryMethotrexateTreatment OutcomeUrinary Bladder NeoplasmsChemotherapy AdjuvantDoxorubicinLymphatic MetastasisFemaleCisplatinNeoplasm Recurrence Localbusinessmedicine.drugEpirubicinFollow-Up StudiesBJU international
researchProduct

Surgery in rhabdomyosarcoma of the bladder, prostate and vagina

1995

The treatment of bladder and prostate rhabdomyosarcoma (RMS) is highly controversial. Aside from chemotherapy, treatment modalities include conservative surgery, radical surgery, and pre-, intra-, or postoperative irradiation. Between 1968 and 1993, 78 children with RMS were treated at our institution. In all, 22 tumors were located in the urogenital tract (bladder/prostate, 13; paratesticular, 5; vaginal, 2; others, 2). Altogether, 6 patients had stage II disease; 7, stage III disease; and 2, stage IV disease. All 15 patients with RMS of the bladder, prostate, or vagina received chemotherapy, and 4 had additional radiotherapy. Surgery was also done in 10 patients; parents refused an operat…

Malemedicine.medical_specialtyVaginal NeoplasmsAdolescentUrologymedicine.medical_treatmentProstate RhabdomyosarcomaVaginal diseaseProstateAntineoplastic Combined Chemotherapy ProtocolsRhabdomyosarcomamedicineHumansRadical surgeryStage (cooking)ChildRhabdomyosarcomaRetrospective StudiesUrinary bladderbusiness.industryInfantProstatic Neoplasmsmedicine.diseaseSurgeryRadiation therapyTreatment Outcomemedicine.anatomical_structureUrinary Bladder NeoplasmsChild PreschoolFemalebusinessFollow-Up StudiesWorld Journal of Urology
researchProduct

Rhabdomyosarcoma of the bladder, prostate or vagina: the role of surgery

2003

Rhabdomyosarcoma of pelvic organs is not common enough for many people to develop large series. However, the authors from Mainz retrospectively analysed 107 children with this condition, and suggest that primary chemotherapy followed by radical surgery yields excellent cure rates. OBJECTIVE To retrospectively analyse the outcome of children with rhabdomyosarcoma (RMS) of the bladder, prostate or vagina who were treated with chemotherapy, with or without radical surgery or additional radiotherapy, at our institution since 1968. PATIENTS AND METHODS From a total of 107 children with RMS seen between 1968 and December 2001, 22 (mean age 5.9, range 0.5–18) had RMS of bladder/prostate or vagina.…

Malemedicine.medical_specialtyVaginal NeoplasmsAdolescentUrologymedicine.medical_treatmentUrologyUrinary DiversionCystectomyAntineoplastic Combined Chemotherapy ProtocolsRhabdomyosarcomamedicineHumansRadical surgeryChildRhabdomyosarcomaRetrospective StudiesProstatectomyIfosfamideUrinary bladderbusiness.industryUrinary diversionInfantProstatic Neoplasmsmedicine.diseaseCombined Modality TherapySurgeryTreatment Outcomemedicine.anatomical_structureUrinary Bladder NeoplasmsBladder augmentationChild PreschoolFemalePouchbusinessContinent Urinary DiversionFollow-Up Studiesmedicine.drugBJU International
researchProduct